Navigation Links
ArmaGen® Re-engineers Erythropoietin for Brain Penetration
Date:7/16/2010

LOS ANGELES, July 16 /PRNewswire/ -- Human erythropoietin (EPO) is a potent neuroprotective agent for multiple brain disorders, including stroke, brain and spinal cord injury, and Parkinson's disease. However, EPO drug development for the brain is limited, because EPO does not cross the blood-brain barrier (BBB). In acute stroke or brain injury, the BBB is intact in the early hours after the insult when neuroprotection is still possible. Therefore, large molecule biopharmaceuticals such as EPO must be re-engineered to enable BBB transport. ArmaGen Technologies has developed the BBB molecular Trojan horse platform technology for solving the BBB drug delivery problem, and has used this technology to create a brain penetrating form of human EPO. ArmaGen® has successfully re-engineered human EPO as an IgG fusion protein that penetrates the brain following intravenous (IV) administration. Human EPO is fused to a genetically engineered monoclonal antibody (MAb) to the human insulin receptor (HIR). The HIRMAb acts as a molecular Trojan horse to ferry the EPO across the BBB via transport on the endogenous BBB insulin receptor. The HIRMAb-EPO fusion protein is a dual receptor specific protein with low nM binding constants for both the human EPO receptor and the human insulin receptor. The HIRMAb part of the HIRMAb-EPO fusion protein cross-reacts with the Rhesus monkey insulin receptor. Therefore, brain penetration of the HIRMAb-EPO fusion protein was demonstrated in vivo in the adult Rhesus monkey following IV administration.  EPO alone was shown not to cross the primate BBB. The brain uptake of the HIRMAb-EPO fusion protein in the Rhesus monkey is high, 2% injected dose/brain, and comparable to the brain uptake of small molecules. The plasma pharmacokinetics (PK) of the HIRMAb-EPO fusion protein differs markedly from the PK of EPO, which minimizes any effect of the fusion protei
'/>"/>

SOURCE ArmaGen Technologies
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Anemic Patients With MDS Gain Long-Term Benefits From Erythropoietin and Myeloid Growth Factor Hormones
2. XTL Biopharmaceuticals Announces the Acquisition of the Use Patent on Recombinant Erythropoietin (rHuEPO) for the Treatment of Multiple Myeloma
3. Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients
4. Unprecedented Donation Made by Mrs. Lily Safra to the Institute for Brain and Spinal Cord Disorders in Paris
5. Physicians See New Benefits, Treatment Opportunities for Brain Cancer with Elektas Leksell Gamma Knife Perfexion
6. Brainlab Collaborates With Toshiba Medical Systems on Integrated Surgical Suite
7. Kendle Advances Early Stage Drug Development with ElMindAs Innovative Brain Network Activation Technology
8. Gamma Knife Users Share Latest Advances for Treating Cancer, Other Brain Disorders at Society Meeting in Greece
9. Elekta Opens a New Window into Human Brain Activity, Focuses on Brain Mets at 2010 AANS Meeting
10. Karolinska University Hospital Acquires Leksell Gamma Knife Perfexion to Expand Radiosurgery Versatility, Efficiency in Brain Cancer Therapy
11. Celtic Pharma Announces Initiation of Pediatric Dose Tolerance Trial Evaluating XERECEPT(R) in Pediatric Patients with Primary and Metastatic Brain Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... WEST CHESTER, Pa. , Sept. 19, 2014 ... Johnson launched two new variable angle plating systems ... this technology, surgeons can adapt screw trajectory to ... screws towards specific fragments of bone. The systems ... Orthopaedic Foot & Ankle Society (AOFAS) and the ...
(Date:9/19/2014)... VIEW, Calif. , Sept. 19, 2014 Today, ... in capital from Xiaomi Ventures, Ltd. for its first ... used to continue expanding iHealth,s global reach, accelerate growth ... resources.  As part of the investment, Xiaomi Ventures will ... the areas of cloud infrastructure and ecommerce. ...
(Date:9/19/2014)... 2014  The board of directors of AbbVie Inc. ... dividend of $0.42 per share.  The ... of record at the close of business on Oct. ... global, research-based biopharmaceutical company formed in 2013 following separation ... expertise, dedicated people and unique approach to innovation to ...
Breaking Medicine Technology:DePuy Synthes Proprietary Variable Angle Locking Technology Now Available To Treat Calcaneal Fractures And Medial Column Fusion Procedures 2DePuy Synthes Proprietary Variable Angle Locking Technology Now Available To Treat Calcaneal Fractures And Medial Column Fusion Procedures 3iHealth Raises $25 Million to Fuel Growth and Global Market Share 2
(Date:9/21/2014)... 21, 2014 “Cluster headaches are sometimes ... and difficult to resolve,” said Steve Young of Ew ... of a pain that is more intense.” , “It ... cluster headaches, or migraines, that medical research is pointing ... system,” he added. , Serotonin (5-HT, 5-hydroxytryptamine) is a ...
(Date:9/21/2014)... 21, 2014 Faculty and staff at Garrison ... preschool in Owings Mills, Md., kicked off the academic year ... bands. GFS is the first independent school to receive the ... and even sleep patterns— as part of a pilot program ... and walking specialty chain. The Vivofit bands are just one ...
(Date:9/21/2014)... Top10BestSEOHosting.com, a leading review website, has recently announced ... most recommended hosting suppliers for the webmasters worldwide ... , “Don’t waste your time on searching ... hosting companies to you,” the IT manager of ... are the most recommended suppliers for everyone. A ...
(Date:9/20/2014)... Diabetes Protocol , a breakthrough ... helping thousands of people learn how to naturally manage ... or prescriptions has caught the attention of Shane Michaels, ... tens of millions of people in the U.S. today ... diabetes, and unfortunately, big pharma makes a killing just ...
(Date:9/20/2014)... GA (PRWEB) September 20, 2014 David ... 20, 2014. The first poster looked at the clinical ... cardiac cycle for calculating diastolic function. In conjunction with ... end-stage renal disease and normal LVEF by echo (>50%). ... stress protocol, and standard SPECT. Emory Toolbox 4.0 ...
Breaking Medicine News(10 mins):Health News:Homeostasis: Equinox Serotonin (5HT) Headache Stories ~ New on the Bryan William Brickner Blog 2Health News:Garrison Forest School Leader in Independent School Wellness Programs 2Health News:Leading Review Website Top10BestSEOHosting.com Unveils The Best Hosting Suppliers In September 2Health News:Diabetes Protocol: Review Exposes Kenneth Pullman’s Breakthrough Discovery About Diabetes Management 2Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 2Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 3
... Reporter , TUESDAY, Nov. 16 (HealthDay News) -- College ... at significantly higher risk for becoming alcohol-dependent, new research ... of energy drinks are more likely to meet the ... Arria, director of the Center on Young Adult Health ...
... states earned a better grade on the 2010 March of Dimes ... Columbia saw their preterm birth rates improve. Following three decades ... in the preterm birth rate, a 4 percent drop from 2006. ... the 2006 final rate of 12.8 percent. The March of Dimes ...
... point mutations mis-spellings in a single letter of ... of cancer cells can be detected successfully in advanced ... opens the way for personalised medicine in which every ... and the appropriate drug chosen to target the mutation ...
... Reporter , TUESDAY, Nov. 16 (HealthDay News) -- U.S. ... recommend approval of the first new drug in more ... The drug, belimumab (Benlysta), is a so-called monoclonal ... systemic lupus erythematosus. Lupus is an autoimmune disease ...
... LANSING, Mich. Transforming vacant urban lots into farms ... majority of their fruits and vegetables. As city ... University study indicates that a combination of urban farms, ... used to extend the growing season could supply ...
... more weight a person gains, the greater the risk that ... blood flow to the heart that can lead to a ... team found that for every 8.8 pound increase in the ... risk for developing ischemic heart disease rose by more than ...
Cached Medicine News:Health News:Energy Drinks May Fuel College Kids' Alcohol Use 2Health News:Energy Drinks May Fuel College Kids' Alcohol Use 3Health News:Preterm birth rates improve in most states 2Health News:Researchers map the way to personalised treatment for ovarian cancer 2Health News:Researchers map the way to personalised treatment for ovarian cancer 3Health News:FDA Advisers Endorse New Lupus Drug 2Health News:FDA Advisers Endorse New Lupus Drug 3Health News:Detroit's urban farms could provide a majority of produce for local residents 2
Rotating 360 degrees, 3 mm x 7 mm bite....
45 degree, forward 3 mm, 4 mm x 5 mm cup, length of shaft 140 mm, overall length 8.3 inches....
20 mm. Plastic, methylmethacrylate. Supplied sterile....
Small right. Teflon orbital plates....
Medicine Products: